-+ 0.00%
-+ 0.00%
-+ 0.00%

ATOSSA THERAPEUTICS RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR (Z)-ENDOXIFEN FOR DUCHENNE MUSCULAR DYSTROPHY

Reuters·12/11/2025 13:00:04

Please log in to view news